Bringing New Horizons to Therapy


General News

Sonolith® i-sys receives FDA approval

EDAP TMS' high-end lithotripter Sonolith® i-sys has just been granted FDA approval. The device is now cleared for routine ESWL treatment in the USA. Sonolith® i-sys obtained CE mark in 2007 and has widely been adopted in Europe since. As all lithotripters from the Sonolith® range, the Sonolith® i-sys uses the exclusive Electroconductive technology for the management of urinary tract stones.
The Sonolith® i-sys superior x-ray and ultrasound imaging systems and user friendly features have contributed to its impressive adoption, positive treatment outcomes and high standards that benefit both patients and hospitals.
Print This Page